申请人:GLAXO GROUP LIMITED
公开号:US20150307485A1
公开(公告)日:2015-10-29
A compound of Formula (I) or a pharmaceutically acceptable salt thereof:
Wherein: Het is a 5 to 10-membered heteroaromatic ring; Either X is N and Y is CR
5
; or X is C and Y is S; Z is selected from N and CH; R
1
is selected from H and C
1-2
alkyl; R
2
is selected from H, C
1-2
alkyl, OH, —CH
2
OH and C
1-2
alkoxy; Each R
3
is independently selected from OH, C
1-3
alkyl, F, Cl, Br, NH
2
, and C
1-3
alkoxy; R
4
is selected from C
1-3
alkyl and haloC
1-3
alkyl; R
5
is selected from H, C
1-3
alkyl and haloC
1-3
alkyl; R
6
and R
7
are either i) each independently selected from H, C
1-3
alkyl and C
1-3
alkoxy; or ii) R
6
and R
7
together with the ring to which they are attached form a 9-membered bicylic ring; p is 0-3; and R
A
is selected from H and C
1-3
alkyl, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.
化合物式(I)或其药学上可接受的盐:其中:Het是5到10个成员的杂环芳基环;X为N且Y为CR5;或X为C且Y为S;Z从N和CH中选择;R1从H和C1-2烷基中选择;R2从H,C1-2烷基,OH,—CH2OH和C1-2烷氧基中选择;每个R3独立地从OH,C1-3烷基,F,Cl,Br,NH2和C1-3烷氧基中选择;R4从C1-3烷基和haloC1-3烷基中选择;R5从H,C1-3烷基和haloC1-3烷基中选择;R6和R7要么i)各自独立地从H,C1-3烷基和C1-3烷氧基中选择;或ii)R6和R7与它们所附着的环一起形成一个9成员的双环;p为0-3;RA从H和C1-3烷基中选择,提供了含有它们的组合物、它们在治疗中的使用,例如在结核病的治疗中,以及制备这种化合物的方法。